ARQT
Arcutis Biotherapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.05B
P/E Ratio
—
EPS
$-0.02
Beta
1.52
52W High
$31.77
52W Low
$12.97
50-Day MA
$22.59
200-Day MA
$23.79
Dividend Yield
—
Profit Margin
-0.57%
Forward P/E
136.99
PEG Ratio
—
About Arcutis Biotherapeutics Inc
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.
Fundamentals
| Revenue (TTM) | $415.62M |
| Gross Profit (TTM) | $377.98M |
| EBITDA | $5.46M |
| Operating Margin | -8.62% |
| Return on Equity | -1.43% |
| Return on Assets | 0.50% |
| Revenue/Share (TTM) | $3.25 |
| Book Value | $1.52 |
| Price-to-Book | 16.22 |
| Price-to-Sales (TTM) | 7.34 |
| EV/Revenue | 7.14 |
| EV/EBITDA | 207.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 60.10% |
| Shares Outstanding | $125.08M |
| Float | $92.58M |
| % Insiders | 1.77% |
| % Institutions | 110.21% |
Historical Volatility
HV 10-Day
50.38%
HV 20-Day
49.01%
HV 30-Day
64.60%
HV 60-Day
58.08%
HV Rank
84.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($34.62 target)
2
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026